Macrogen Inc. is engaged in research and development of basic tools for genome medicine including genetic information analysis to functional genomics. The company invented 'Super Alcohol Bacteria' and a congenital-hereditary-disease diagnosing kit. Macrogen Inc. also commercialized genetically engineered mice production, cloning and xenotransplant technology. The company operates in five business divisions: Sequencing is engaged in research projects such as Korea Genome BAC Clone Map and Zymomonas mobilis Genome Project; Oligo provides Oligo Synthesis services such as MOPCTM purification method; Biochip provides DNA Chip total solution including MacArray™ Express Oligochip, MacArray™ Karyo and MacProbe™; Mouse is engaged in functional genomics research providing transgenic/knockout mice; and Bioinformatics is engaged in providing BT & IT human resources services including database construction, Genome Research, and Bioinformatics comprehensive analysis system consulting services. The company is based in Seoul, South Korea with affiliated companies in markets including USA, Japan, and Europe. Macrogen Inc. was incorporated in 1997.
Headquarters
10F Word Merdian Venture Center, 60-24 Gasan-Dong, Geumcheon-Gu
Seoul; Seoul;
Postal Code: 153-801
Contact Details: Purchase the Macrogen Inc. report to view the information.
Website: http://www.macrogen.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service